On September 13, 2019 the Food and Drug Administration issued a warning that the heartburn medicine Zantac (generic ranitidine) contains the cancer-causing chemical NDMA.
Each Zantac tablet has been found to contain 3,000 to 26,000 times the FDA approved amount of NDMA that can be safely ingested daily.
The FDA issued a warning after a pharmacy in Connecticut discovered elevated levels of NDMA while testing Zantac. It has been reported that the levels of cancer-causing NDMA are anywhere from 3,000 to 26,000 times higher than the legally allowable limit set by the FDA.
Zantac and its generic versions pulled from shelves of Walmart, Rite Aid, CVS and Walgreens stores after the FDA announced that it had detected the cancer-causing chemical in samples of the drug.
You may qualify for a lawsuit if you have developed any form of cancer after taking Zantac:
- Liver cancer
- Kidney cancer
- Lung cancer
- Intestinal cancer
- Stomach cancer
- Pancreatic cancer
- Colon cancer
- Ovarian cancer
- Esophageal cancer
- Testicular Cancer
- And more
